Nurofen Plus Malta - English - Medicines Authority

nurofen plus

reckitt benckiser healthcare (uk) limited 103-105 bath road slough sl1 3uh, united kingdom - codeine phosphate, hemihydrate, ibuprofen - tablet - codeine phosphate hemihydrate 12.8 milligram(s) ; ibuprofen 200 milligram(s) - antiinflammatory and antirheumatic products

APFEN PLUS 200/12.8 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

apfen plus 200/12.8 milligram film coated tablet

glaxosmithkline consumer healthcare (ireland) limited - ibuprofen, codeine phosphate hemihydrate - film coated tablet - 200/12.8 milligram - codeine and ibuprofen

Maxilief Effervescent Tablets Paracetamol 500mg Codeine Phosphate Hemihydrate 8mg Caffeine 30mg Ireland - English - HPRA (Health Products Regulatory Authority)

maxilief effervescent tablets paracetamol 500mg codeine phosphate hemihydrate 8mg caffeine 30mg

clonmel healthcare ltd - paracetamol; codeine phosphate hemihydrate; caffeine - effervescent tablet - 500/8/30 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

CODEINE SULFATE tablet United States - English - NLM (National Library of Medicine)

codeine sulfate tablet

lannett company, inc. - codeine sulfate (unii: 11qv9bs0cb) (codeine anhydrous - unii:ux6owy2v7j) - codeine sulfate 15 mg - codeine sulfate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [ s ee warnings and precautions ( 5.1 ) ] , reserve codeine sulfate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: - have not been tolerated, or are not expected to be tolerated. have not been tolerated, or are not expected to be tolerated. - have not provided adequate analgesia, or are not expected to provide adequate analgesia. have not provided adequate analgesia, or are not expected to provide adequate analgesia. codeine sulfate tablets are contraindicated for: - all children younger than 12 years of age [see warnings and precautions ( 5.4 )] . - post-operative management in children younger than 18 years of age following tonsillect

PANADEINE FORTE paracetamol 500mg and codeine phosphate hemihydrate 30mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

panadeine forte paracetamol 500mg and codeine phosphate hemihydrate 30mg tablet blister pack

sanofi-aventis australia pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 30 mg - tablet, uncoated - excipient ingredients: potassium sorbate; maize starch; povidone; purified talc; stearic acid; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch - panadeine forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

MEDCO IBUPROFEN 200 and CODEINE PHOSPHATE 12.8 ibuprofen 200 mg and codeine phosphate hemihydrate 12.8 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

medco ibuprofen 200 and codeine phosphate 12.8 ibuprofen 200 mg and codeine phosphate hemihydrate 12.8 mg tablet blister pack

soul pattinson manufacturing pty ltd - codeine phosphate hemihydrate, quantity: 12.8 mg; ibuprofen, quantity: 200 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; pregelatinised maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - for the temporary relief of acute moderate pain and inflammation

IBUDEINE tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

ibudeine tablet blister pack

arrotex pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 12.8 mg; ibuprofen, quantity: 200 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; purified water; magnesium stearate; glyceryl behenate; maize starch; titanium dioxide; hypromellose; macrogol 6000 - for temporary relief of acute moderate pain and inflammation

NUROFEN PLUS tablet blister pack (reformulation) Australia - English - Department of Health (Therapeutic Goods Administration)

nurofen plus tablet blister pack (reformulation)

reckitt benckiser pty ltd - ibuprofen, quantity: 200 mg; codeine phosphate hemihydrate, quantity: 12.8 mg - tablet, film coated - excipient ingredients: hypromellose; sodium starch glycollate; microcrystalline cellulose; purified talc; pregelatinised maize starch; titanium dioxide; purified water; industrial methylated spirit - for the temporary relief of acute moderate pain and inflammation in patients over the age of 12 years ( see also contraindications and paediatric use)